Acarix As Stock Five Year Return
ACARIX Stock | SEK 0.26 0.01 3.70% |
Acarix AS fundamentals help investors to digest information that contributes to Acarix AS's financial success or failures. It also enables traders to predict the movement of Acarix Stock. The fundamental analysis module provides a way to measure Acarix AS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acarix AS stock.
Acarix |
Acarix AS Company Five Year Return Analysis
Acarix AS's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Acarix AS has a Five Year Return of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Acarix Fundamentals
Return On Equity | -1.46 | |||
Return On Asset | -0.8 | |||
Operating Margin | (13.75) % | |||
Current Valuation | 51.77 M | |||
Shares Outstanding | 373.33 M | |||
Shares Owned By Insiders | 10.28 % | |||
Shares Owned By Institutions | 2.84 % | |||
Price To Book | 1.63 X | |||
Price To Sales | 15.38 X | |||
Revenue | 3.76 M | |||
Gross Profit | 2.82 M | |||
EBITDA | (48.28 M) | |||
Net Income | (51.73 M) | |||
Cash And Equivalents | 15.86 M | |||
Cash Per Share | 2.24 X | |||
Total Debt | 239 K | |||
Debt To Equity | 2.30 % | |||
Current Ratio | 7.38 X | |||
Book Value Per Share | 0.20 X | |||
Cash Flow From Operations | (48.01 M) | |||
Earnings Per Share | (0.31) X | |||
Target Price | 0.75 | |||
Beta | 1.65 | |||
Market Capitalization | 107.15 M | |||
Total Asset | 118.6 M | |||
Net Asset | 118.6 M |
About Acarix AS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acarix AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acarix AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acarix AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Acarix Stock
Acarix AS financial ratios help investors to determine whether Acarix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acarix with respect to the benefits of owning Acarix AS security.